[Oral glycoprotein IIb/IIIa-inhibitors inhibit platelet aggregation: an aid against unstable coronary syndrome and recurrent stenosis after angioplasty. Satellite symposia within the 22nd Congress of the European Cardiology Society].
D000789:Angina, Unstable / Q000188:drug therapy / Q000517:prevention & control; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D009204:Myocardial Revascularization; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex
Orale Glycoprotein IIb/IIIa-Inhibitoren verhindern Plättchen-Aggregation: Hilfe gegen instabile koronare Syndrome und erneute Stenosen nach Angioplastie. Satelliten-Symposien im Rahmen des 22. Kongresses der Europäischen Gesellschaft für Kardiologie.